1. Flosequinan for congestive heart failure: What promise does it hold?

   • J. R. Hampton

   Editorial Pages: 1313 - 1315

2. Introduction to focused section on calcium antagonists and the kidney

   • Murray Epstein

   Focused Subsection: Calcium Antagonists and the Kidney Pages: 1317 - 1318

3. Calcium handling by renal tubules during oxygen deprivation injury to the kidney prior to reoxygenation

   • Thomas J. Burke
   • Harmeet Singh
   • Robert W. Schrier

   Focused Subsection: Calcium Antagonists and the Kidney Pages: 1319 - 1324

4. Impact of calcium entry blockers on glomerular injury in experimental hypertension

   • Lance D. Dworkin

   Focused Subsection: Calcium Antagonists and the Kidney Pages: 1325 - 1330

5. Effects of calcium antagonists on the hypertensive kidney

   • Garry P. Reams
   • John H. Bauer

   Focused Subsection: Calcium Antagonists and the Kidney Pages: 1331 - 1335

6. French multicenter trial of anistreplase versus heparin in acute myocardial infarction

   • H. Lardoux
   • Y. Louvard
   • B. Letac

   Clinical Trials Pages: 1337 - 1344

7. KT-362 related effects on intracellular calcium release and associated clinical potential: Arrhythmias, myocardial ischemia, and hypertension

   • R. Kelly Hester
   • Shoji Shibata

   Review Section Pages: 1345 - 1354

8. The role of calcium in the control of vascular tone as assessed by the Ca²⁺ indicator aequorin

   • Kathleen G. Morgan

   Review Section Pages: 1355 - 1362

9. Left ventricular dilatation and failure post-myocardial infarction: Pathophysiology and possible pharmacologic interventions

   • Brian G. Firth
   • Preston M. Dunnmon

   Review Section Pages: 1363 - 1374

10. ACE inhibitors for the treatment of myocardial ischemia?

    • Christa Linder
    • Gerd Heusch

    Review Section Pages: 1375 - 1384

11. Clinical Relevance of hyperlipidemia

    • Mario Mancini
    • Paolo Pauciullo

    Lipid Studies Pages: 1385 - 1388

12. Effects of therapy with diet and simvastatin on atherosclerosis in hypercholesterolemic patients

    • Clifford W. Barlow
    • Brian M. Friedman
    • David H. G. Smith

    Lipid Studies Pages: 1389 - 1394

13. Exercise capacity, hemodynamic, and neurohumoral changes following acute and chronic administration of flosequinan in chronic congestive heart failure

    • Günter A. J. Riegger
    • Heinz Kahles
    • Kurt Kochsiek

    Heart Failure Pages: 1395 - 1402

14. Enoximone: True inotropic effects? Do they cause ischemia? Analysis of end-systolic pressure-volume relations using the conductance (volume) Catheter technique

    • Jochen Thormann
    • Juergen Hueting
    • Martin Schlepper

    Heart Failure Pages: 1403 - 1415

15. Depressor effects and pharmacokinetics of single and consecutive doses of delapril in hypertensive patients with normal or impaired renal function

    • Kohsuke Minamisawa
    • Hiroshi Shionoiri
    • Masao Ishii

    Hypertention Pages: 1417 - 1423

16. Sotalol in patients with life-threatening ventricular tachyarrhythmias

    • Hans-Joachim Trappe
    • Helmut Klein
    • Paul Lichtlen

    Arrhythmias Pages: 1425 - 1432